Caplight Directory>Companies>POLYGON Therapeutics-preview>Polygon-care


POLYGON Therapeutics

POLYGON Therapeutics

Private
ParisN/Ahttps://www.polygon.care/

Last Round

Seed

Nov 8, 2024

Total Funding Raised

$8M

Momentum Score

25 /100

Company Overview

POLYGON Therapeutics is a drug discovery company that provides a therapeutic development program to improve cardiovascular disease care and mitigate the damage inflicted on the heart.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

POLYGON Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

POLYGON Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 8, 2024
GrantApr 18, 2023
Pre SeedSep 8, 2022
GrantJul 7, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Hafid Ait-Oufella

Co-founder CMO & CSO

Founding Team

Tatiana Monseur

Co-Founder, COO & CFO

Founding Team

Mohamed ABOU ALI

Chief Executive Officer, Co-Founder

Founding Team

POLYGON Therapeutics Investors

Notable investors and investment history

InvestorRounds
AgoranovPre Seed
Région Île-de-FranceGrant
AudaciaSeed
Inserm TransfertPre Seed
EIT HealthSeed
Sorbonne VentureSeed
BpifranceGrant, Pre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors increased 42% MoM.

  • Feb 23, 2025

    Monthly visitors grew 408% MoM.

View all signals

POLYGON Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

POLYGON Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about POLYGON Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range9
Year Founded2021
Last FundingNov 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.